Sale of 1,452 shares at $25 per share.
Reporting Person Hansen Gwenn · Officer Title Chief Scientific Officer · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 15, 2026
Source: SEC Form 4 · 0001817160-26-000021 · filed 2026-10-15 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Nurix Therapeutics, Inc. (NRIX)." Disclosed 2026-10-15. https://desqlong.com/cards/0001817160-26-000021-2 (retrieved 2026-10-16).